Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jul 26, 2022	CORRESP	CORRESP	View HTML 0001140361-22-027002.pdf 0001140361-22-027002.rtf 0001140361-22-027002.xls
Jul 28, 2022	EFFECT	EFFECT	View HTML 9999999995-22-002194.pdf 9999999995-22-002194.rtf 9999999995-22-002194.xls
Jul 29, 2022	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001140361-22-027443.pdf 0001140361-22-027443.rtf 0001140361-22-027443.xls
Aug 4, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000320017-22-000057.pdf 0000320017-22-000057.rtf 0000320017-22-000057.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 5, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-22-000061.pdf 0000320017-22-000061.rtf 0000320017-22-000061.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 10, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000064.pdf 0000320017-22-000064.rtf
Aug 15, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000067.pdf 0000320017-22-000067.rtf
Aug 19, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-22-000071.pdf 0000320017-22-000071.rtf 0000320017-22-000071.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 2, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000074.pdf 0000320017-22-000074.rtf
Sep 2, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001879231-22-000006.pdf 0001879231-22-000006.rtf 0001879231-22-000006.xls